SCHEMBL1947841

SCHEMBL1947841

CC(O)COC(C)COC(C)C(C)(O)NC(C)(O)C(C)OCC(C)OCC(C)O

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.43
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1759721 0.77 TDP1 (0.46) TDP1MAPK1
SCHEMBL482801 0.73 MAPK1 (0.48) TDP1MAPK1
SCHEMBL3395409 0.72 MAPK1 (0.67) TDP1MAPK1
SCHEMBL350593 0.72 MAPK1 (0.67) TDP1MAPK1
SCHEMBL10587586 0.71 TDP1 (0.52) TDP1MAPK1
SCHEMBL3796517 0.71 TDP1 (0.52) TDP1MAPK1
SCHEMBL535994 0.71 TDP1 (0.56) TDP1MAPK1
SCHEMBL17504736 0.71 TDP1 (0.68) TDP1MAPK1
SCHEMBL8989517 0.71 TDP1 (0.68) TDP1MAPK1
SCHEMBL137830 0.71 TDP1 (0.56) TDP1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130255535-A1 CZTSe NANOINK COMPOSITION AND SPUTTERING TARGET THEREOF SHEI, SHIH-CHANG (TW) 2013-10-03 US claimed
US-20130025497-A1 NANOINK FOR FORMING ABSORBER LAYER OF THIN FILM SOLAR CELL AND METHOD OF PRODUCING THE SAME WANG CHI-JIE (TW) 2013-01-31 US claimed
US-20110137061-A1 NANOINK FOR FORMING ABSORBER LAYER OF THIN FILM SOLAR CELL AND METHOD OF PRODUCING THE SAME WANG, KUAN-CHE (TW) 2011-06-09 US claimed
US-20130255535-A1 CZTSe NANOINK COMPOSITION AND SPUTTERING TARGET THEREOF SHEI, SHIH-CHANG (TW) 2013-10-03 US disclosed
US-20130025497-A1 NANOINK FOR FORMING ABSORBER LAYER OF THIN FILM SOLAR CELL AND METHOD OF PRODUCING THE SAME WANG CHI-JIE (TW) 2013-01-31 US disclosed
US-8071814-B2 Process for preparing polyetheramines CLARIANT FINANCE (BVI) LIMITED (VG) 2011-12-06 US disclosed
US-20110137061-A1 NANOINK FOR FORMING ABSORBER LAYER OF THIN FILM SOLAR CELL AND METHOD OF PRODUCING THE SAME WANG, KUAN-CHE (TW) 2011-06-09 US disclosed
US-7696385-B2 Polyetheramine production method CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) 2010-04-13 US disclosed
US-20100069671-A1 Process For Preparing Polyetheramines CLARIANT FINANCE (BVI) LIMITED (VG) 2010-03-18 US disclosed
US-20090177013-A1 Polyetheramine Production Method CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) 2009-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090177013-A1 Polyetheramine Production Method PNMT, HRH3, HRH4 TDP1 3483/4885MAPK1 1966/4885
US-20100069671-A1 Process For Preparing Polyetheramines OXER1, OXGR1, NR1H3 TDP1 4742/4885MAPK1 2467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.